Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $9.42 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.08.
Market Cap
9.42T
Revenue
4.67T
Profits
188.03B
PE Ratio
50.08
Profit Margin
4.03%
Dividend Yield
0.38%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | - | 2,220,270 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 663.28B | - | 4,320,878 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 453.19B | - | 4,729,801 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 370.89B | - | 4,397,468 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 356.47B | -0.95% | 5,566,518 | 450.53B |
| 6 | NVS | Novartis AG | 294.81B | -1.90% | 1,294,324 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 252.95B | - | 3,073,349 | 61.37B |
| 8 | AMGN | Amgen Inc. | 236.38B | -1.55% | 1,656,089 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 226.94B | - | 1,229,135 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 205.74B | - | 6,219,243 | 50.34B |
| 11 | ABT | Abbott Laboratories | 187.45B | - | 7,029,455 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 187.23B | -0.15% | 6,181,783 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.16B | -1.25% | 23,791,956 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.98B | - | 2,898,176 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.42B | - | 803,524 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.49B | - | 4,825,447 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 129.55B | -0.85% | 2,081,783 | 11.03B |
| 18 | CVS | CVS Health Corporation | 123.73B | - | 4,499,060 | 412.65B |
| 19 | MDT | Medtronic plc | 120.46B | - | 9,013,901 | 37.54B |
| 20 | SYK | Stryker Corporation | 116.27B | -1.58% | 2,401,462 | 25.84B |
| 21 | MCK | McKesson Corporation | 105.86B | - | 879,268 | 410.98B |
| 22 | SNY | Sanofi | 105.44B | -0.20% | 1,695,047 | 55.89B |
| 23 | GSK | GSK plc | 99.72B | -1.93% | 2,287,091 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 88.37B | - | 1,132,883 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 87.68B | - | 971,433 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.65B | - | 561,170 | 15.53B |
| 27 | CI | The Cigna Group | 74.65B | - | 1,204,767 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.27B | 1.81% | 15,504,234 | 21.00B |
| 29 | ARGX | argenx SE | 63.22B | - | 125,058 | 5.32B |
| 30 | COR | Cencora, Inc. | 63.15B | - | 1,027,638 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.62B | -1.39% | 1,499,547 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.11B | -2.23% | 14,966,547 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 57.49B | - | 1,548,360 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.82B | - | 2,635,295 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 50.32B | - | 1,439,133 | 22.48B |
| 36 | HUM | Humana Inc. | 48.22B | - | 783,105 | 145.68B |
| 37 | MDLN | Medline Inc. | 48.11B | - | 5,244,069 | 29.94B |
| 38 | NTRA | Natera, Inc. | 47.31B | - | 968,222 | 2.71B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.01B | - | 885,061 | - |
| 40 | VEEV | Veeva Systems Inc. | 44.54B | - | 1,152,404 | 3.46B |
| 41 | IQV | IQVIA Holdings Inc. | 44.07B | - | 1,197,937 | 16.98B |
| 42 | A | Agilent Technologies, Inc. | 42.53B | - | 1,825,450 | 7.37B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 42.37B | -0.71% | 7,402,523 | 17.32B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 42.18B | - | 407,845 | 4.55B |
| 45 | HLN | Haleon plc | 40.96B | - | 18,166,344 | 14.80B |
| 46 | ONC | BeOne Medicines AG | 40.73B | - | 202,358 | 6.13B |
| 47 | WAT | Waters Corporation | 40.22B | - | 352,083 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 36.78B | 0.13% | 3,402,567 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.61B | - | 1,431,221 | 4.80B |
| 50 | ALC | Alcon Inc. | 34.04B | - | 1,341,022 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 33.17B | - | 2,361,537 | 4.97B |
| 52 | CNC | Centene Corporation | 33.12B | - | 2,926,371 | 180.30B |
| 53 | ILMN | Illumina, Inc. | 32.95B | - | 1,748,198 | 4.49B |
| 54 | RMD | ResMed Inc. | 32.94B | - | 843,837 | 5.65B |
| 55 | BIIB | Biogen Inc. | 32.63B | - | 465,108 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 31.33B | -0.63% | 4,170,458 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.10B | -1.23% | 2,812,732 | 21.27B |
| 58 | INSM | Insmed Incorporated | 27.58B | - | 1,802,693 | 1.14B |
| 59 | MTD | Mettler-Toledo International Inc. | 26.95B | - | 103,033 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 26.51B | - | 438,652 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.17B | - | 798,704 | 11.56B |
| 62 | BNTX | BioNTech SE | 26.06B | - | 626,059 | 3.03B |
| 63 | INCY | Incyte Corporation | 25.69B | - | 1,036,073 | 5.82B |
| 64 | ROIV | Roivant Sciences Ltd. | 25.23B | - | 5,240,613 | 7.53M |
| 65 | PHG | Koninklijke Philips N.V. | 25.13B | - | 455,477 | 20.18B |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.93B | - | 364,084 | 3.33B |
| 67 | STE | STERIS plc | 21.90B | - | 567,998 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 21.66B | - | 2,402,454 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.34B | - | 557,693 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 20.91B | - | 327,025 | 3.15B |
| 71 | GMAB | Genmab A/S | 19.89B | - | 1,002,606 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.39B | - | 5,732,791 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.71B | - | 1,325,048 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.77B | - | 723,516 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.50B | - | 146,431 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.02B | - | 321,870 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.82B | - | 933,570 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.61B | - | 576,351 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.63B | - | 1,539,365 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.62B | - | 1,580,989 | 2.44B |
| 81 | RVTY | Revvity, Inc. | 14.53B | - | 1,175,229 | 2.91B |
| 82 | SMMT | Summit Therapeutics Inc. | 14.04B | 2.77% | 6,946,115 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.77B | - | 738,889 | 4.00B |
| 84 | COO | The Cooper Companies, Inc. | 13.57B | - | 1,957,081 | 4.23B |
| 85 | BAX | Baxter International Inc. | 13.35B | - | 3,415,197 | 11.47B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.88B | 0.15% | 2,299,208 | 3.41B |
| 87 | ICLR | ICON Public Limited Company | 12.72B | - | 796,397 | 8.29B |
| 88 | PEN | Penumbra, Inc. | 12.69B | - | 174,066 | 1.50B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.65B | - | 1,729,143 | 14.37B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.51B | - | 1,010,602 | 1.66B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.50B | - | 177,171 | 1.28B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.24B | - | 3,718,067 | 5.02B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.20B | - | 757,847 | 669.50M |
| 94 | SNN | Smith & Nephew plc | 12.12B | - | 851,038 | 6.30B |
| 95 | FMS | Fresenius Medical Care AG | 12.11B | - | 480,312 | 22.19B |
| 96 | CORT | Corcept Therapeutics Incorporated | 12.07B | - | 604,557 | 830.81M |
| 97 | EHC | Encompass Health Corporation | 12.01B | - | 517,751 | 6.21B |
| 98 | DVA | DaVita Inc. | 11.73B | - | 473,725 | 14.01B |
| 99 | TEM | Tempus AI, Inc. | 11.66B | - | 4,574,980 | 1.43B |
| 100 | TECH | Bio-Techne Corporation | 11.36B | - | 1,856,314 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.27B | - | 990,519 | 4.14B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 10.83B | - | 438,242 | 776.57M |
| 103 | KRYS | Krystal Biotech, Inc. | 10.60B | - | 323,022 | 440.48M |
| 104 | GMED | Globus Medical, Inc. | 10.51B | 0.22% | 1,123,661 | 3.14B |
| 105 | GKOS | Glaukos Corporation | 10.46B | - | 572,538 | 612.84M |
| 106 | MOH | Molina Healthcare, Inc. | 10.46B | - | 258,291 | 42.47B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.32B | - | 112,951 | 2.59B |
| 108 | PODD | Insulet Corporation | 10.23B | - | 1,058,435 | 3.05B |
| 109 | AVTR | Avantor, Inc. | 10.13B | - | 7,654,023 | 6.56B |
| 110 | CYTK | Cytokinetics, Incorporated | 10.11B | - | 1,140,923 | 67.67M |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.08B | - | 2,343,590 | 3.50B |
| 112 | HSIC | Henry Schein, Inc. | 10.01B | - | 887,874 | 13.60B |
| 113 | UHS | Universal Health Services, Inc. | 10.00B | - | 428,934 | 18.11B |
| 114 | OSCR | Oscar Health, Inc. | 9.94B | - | 3,689,944 | 15.32B |
| 115 | ABVX | ABIVAX Société Anonyme | 9.93B | 0.66% | 489,816 | 5.67M |
| 116 | ENSG | The Ensign Group, Inc. | 9.87B | - | 270,479 | 5.49B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.82B | - | 175,356 | 7.46M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.76B | - | 378,568 | 105.00M |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 9.65B | -0.07% | 2,671,092 | 874.09M |
| 120 | RGEN | Repligen Corporation | 9.46B | - | 806,067 | 785.10M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.43B | - | 501,305 | 281.99M |
| 122 | PCVX | Vaxcyte, Inc. | 9.10B | - | 986,707 | - |
| 123 | QGEN | Qiagen N.V. | 8.99B | - | 1,922,422 | 2.10B |
| 124 | BRKR | Bruker Corporation | 8.91B | - | 1,334,185 | 3.50B |
| 125 | IBRX | ImmunityBio, Inc. | 8.56B | - | 4,330,218 | 165.79M |
| 126 | TXG | 10x Genomics, Inc. | 8.16B | - | 1,469,824 | 616.91M |
| 127 | IMVT | Immunovant, Inc. | 8.11B | - | 765,743 | - |
| 128 | ATR | AptarGroup, Inc. | 8.10B | - | 323,987 | 3.93B |
| 129 | HQY | HealthEquity, Inc. | 7.95B | - | 432,486 | 1.36B |
| 130 | TGTX | TG Therapeutics, Inc. | 7.94B | -0.01% | 992,966 | 799.54M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.85B | - | 803,857 | - |
| 132 | TWST | Twist Bioscience Corporation | 7.82B | - | 901,851 | 431.80M |
| 133 | BLTE | Belite Bio, Inc | 7.80B | - | 738,953 | - |
| 134 | ALKS | Alkermes plc | 7.73B | - | 1,064,035 | 1.67B |
| 135 | HNGE | Hinge Health, Inc. | 7.45B | 1.77% | 1,179,523 | 720.06M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.08B | - | 4,711,320 | 989.61M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.07B | - | 466,907 | 239.92M |
| 138 | GRFS | Grifols, S.A. | 6.85B | - | 157,912 | 8.48B |
| 139 | CHE | Chemed Corporation | 6.77B | - | 84,283 | 2.60B |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.74B | - | 658,049 | - |
| 141 | PACS | PACS Group, Inc. | 6.73B | - | 649,463 | 5.55B |
| 142 | CGON | CG Oncology, Inc. | 6.62B | - | 282,523 | 6.23M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.59B | - | 859,897 | 1.56B |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 6.55B | - | 350,960 | 618.07M |
| 145 | MMED | MiniMed Group, Inc. | 6.54B | - | 1,719,503 | 3.22B |
| 146 | HIMS | Hims & Hers Health, Inc. | 6.47B | -0.40% | 7,181,866 | 2.58B |
| 147 | BLCO | Bausch + Lomb Corporation | 6.44B | - | 414,107 | 5.32B |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.15B | - | 1,050,705 | 591.33M |
| 149 | LQDA | Liquidia Corporation | 6.15B | - | 902,384 | 450.91M |
| 150 | ORKA | Oruka Therapeutics, Inc. | 6.13B | - | 600,471 | - |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.08B | - | 430,046 | 840.85M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.07B | - | 1,440,974 | 3.12B |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.05B | - | 638,559 | 1.90M |
| 154 | COGT | Cogent Biosciences, Inc. | 6.03B | - | 784,081 | - |
| 155 | TFX | Teleflex Incorporated | 5.86B | - | 464,473 | 2.25B |
| 156 | RDNT | RadNet, Inc. | 5.80B | - | 502,017 | 2.27B |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 5.79B | - | 459,231 | 7.50M |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.78B | - | 673,540 | 1.01B |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.69B | - | 132,389 | 290.54M |
| 160 | ERAS | Erasca, Inc. | 5.66B | - | 2,055,114 | - |
| 161 | STVN | Stevanato Group S.p.A. | 5.60B | - | 212,894 | 1.40B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.39B | -1.24% | 904,292 | 13.39M |
| 163 | SHC | Sotera Health Company | 5.39B | - | 1,215,653 | 1.22B |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.35B | - | 599,643 | 1.58B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.12B | - | 1,128,929 | - |
| 166 | PBLS | Parabilis Medicines, Inc. | 4.99B | - | 380,843 | 148.00K |
| 167 | LFST | LifeStance Health Group, Inc. | 4.86B | - | 2,043,809 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.83B | - | 1,682,950 | 1.14B |
| 169 | WAY | Waystar Holding Corp. | 4.81B | - | 893,703 | 1.21B |
| 170 | DOCS | Doximity, Inc. | 4.70B | - | 1,984,711 | 655.57M |
| 171 | BLLN | BillionToOne, Inc. | 4.69B | - | 976,446 | 397.41M |
| 172 | CELC | Celcuity Inc. | 4.68B | - | 515,521 | - |
| 173 | HAE | Haemonetics Corporation | 4.68B | - | 425,088 | 1.35B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.68B | - | 826,755 | - |
| 175 | DYN | Dyne Therapeutics, Inc. | 4.53B | -2.69% | 1,588,059 | - |
| 176 | LIVN | LivaNova PLC | 4.51B | - | 334,168 | 1.47B |
| 177 | CON | Concentra Group Holdings Parent, Inc. | 4.40B | - | 363,453 | 2.29B |
| 178 | NVST | Envista Holdings Corporation | 4.38B | - | 1,682,158 | 2.86B |
| 179 | ELVN | Enliven Therapeutics, Inc. | 4.35B | - | 1,113,062 | - |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | - | 1,610,993 | 1.84B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.28B | - | 885,519 | -665.00K |
| 182 | HTFL | HeartFlow, Inc. | 4.25B | - | 1,407,076 | 212.07M |
| 183 | ICUI | ICU Medical, Inc. | 4.19B | - | 163,496 | 2.16B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.17B | 0.16% | 2,054,847 | 10.35M |
| 185 | LEGN | Legend Biotech Corporation | 4.17B | - | 812,414 | 1.27B |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.12B | - | 1,019,385 | 1.33B |
| 187 | MANE | Veradermics, Incorporated | 4.12B | - | 363,236 | - |
| 188 | VKTX | Viking Therapeutics, Inc. | 4.07B | - | 1,402,465 | - |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.06B | - | 444,544 | 825.34M |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.99B | - | 142,007 | 890.79M |
| 191 | TARS | Tarsus Pharmaceuticals, Inc. | 3.98B | - | 1,595,936 | 606.33M |
| 192 | IOVA | Iovance Biotherapeutics, Inc. | 3.98B | - | 8,079,576 | 324.97M |
| 193 | ADPT | Adaptive Biotechnologies Corporation | 3.87B | - | 1,404,316 | 308.08M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | - | 448,008 | 234.13M |
| 195 | PLSE | Pulse Biosciences, Inc. | 3.80B | - | 515,420 | 1.19M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.80B | - | 1,457,381 | 53.81M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.78B | - | 736,982 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.70B | -1.21% | 2,019,253 | 66.17M |
| 199 | OPCH | Option Care Health, Inc. | 3.63B | - | 1,155,768 | 5.69B |
| 200 | OGN | Organon & Co. | 3.62B | - | 4,872,489 | 6.13B |
| 201 | GRAL | GRAIL, Inc. | 3.59B | - | 434,821 | 165.26M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.56B | - | 799,633 | 3.60M |
| 203 | NHC | National HealthCare Corporation | 3.42B | - | 61,030 | 1.56B |
| 204 | VCYT | Veracyte, Inc. | 3.42B | - | 992,183 | 561.90M |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.41B | - | 659,354 | - |
| 206 | GPCR | Structure Therapeutics Inc. | 3.38B | - | 281,709 | - |
| 207 | TMDX | TransMedics Group, Inc. | 3.12B | - | 542,804 | 668.47M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.12B | - | 414,532 | 158.00K |
| 209 | QURE | uniQure N.V. | 3.09B | - | 991,476 | 18.67M |
| 210 | IRON | Disc Medicine, Inc. | 3.04B | - | 204,857 | - |
| 211 | IMNM | Immunome, Inc. | 3.04B | - | 562,401 | 4.02M |
| 212 | NAMS | NewAmsterdam Pharma Company N.V. | 3.04B | - | 709,503 | 7.12M |
| 213 | WRBY | Warby Parker Inc. | 3.01B | - | 3,054,452 | 911.61M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 1.01% | 1,631,999 | 463.98M |
| 215 | MBX | MBX Biosciences, Inc. | 2.97B | - | 271,775 | - |
| 216 | BEAM | Beam Therapeutics Inc. | 2.96B | - | 1,183,164 | 156.04M |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.96B | - | 1,844,326 | 2.60B |
| 218 | ZLAB | Zai Lab Limited | 2.94B | - | 812,771 | 449.61M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.81B | - | 3,222,765 | 2.93B |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.81B | - | 5,101,084 | 4.58B |
| 221 | SLS | SELLAS Life Sciences Group, Inc. | 2.80B | 1.17% | 4,526,880 | - |
| 222 | ATAI | AtaiBeckley Inc. | 2.74B | 0.68% | 10,313,859 | 4.47M |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.71B | - | 1,232,151 | 36.77M |
| 224 | PRVA | Privia Health Group, Inc. | 2.64B | - | 869,323 | 2.36B |
| 225 | CDNA | CareDx, Inc. | 2.63B | - | 1,307,395 | 458.09M |
| 226 | ATRC | AtriCure, Inc. | 2.62B | - | 714,570 | 569.62M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.62B | - | 835,045 | 3.37B |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.60B | - | 759,915 | 71.13M |
| 229 | AXGN | Axogen, Inc. | 2.60B | - | 550,070 | 251.17M |
| 230 | VERA | Vera Therapeutics, Inc. | 2.59B | - | 1,184,659 | - |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | - | 418,372 | 1.46B |
| 232 | NEOG | Neogen Corporation | 2.58B | - | 1,263,005 | 870.40M |
| 233 | WGS | GeneDx Holdings Corp. | 2.56B | - | 304,440 | 454.43M |
| 234 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.55B | - | 1,495,740 | 940.61M |
| 235 | PGEN | Precigen, Inc. | 2.54B | - | 2,192,987 | 85.72M |
| 236 | NKTR | Nektar Therapeutics | 2.53B | - | 607,432 | 54.59M |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.53B | - | 444,197 | 830.44M |
| 238 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | - | 643,518 | - |
| 239 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | - | 342,930 | 1.10B |
| 240 | PHVS | Pharvaris N.V. | 2.47B | - | 483,983 | - |
| 241 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | - | 662,547 | 959.90M |
| 242 | TRVI | Trevi Therapeutics, Inc. | 2.46B | - | 856,672 | - |
| 243 | BHC | Bausch Health Companies Inc. | 2.45B | - | 1,652,776 | 10.85B |
| 244 | HCM | HUTCHMED (China) Limited | 2.44B | - | 150,500 | 549.12M |
| 245 | NUVB | Nuvation Bio Inc. | 2.39B | 0.59% | 3,755,288 | 169.90M |
| 246 | SRPT | Sarepta Therapeutics, Inc. | 2.38B | -2.13% | 2,955,533 | 1.97B |
| 247 | BHVN | Biohaven Ltd. | 2.37B | -1.07% | 1,901,047 | - |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.34B | - | 1,306,872 | 52.06M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.33B | - | 1,371,950 | 1.14B |
| 250 | XRAY | DENTSPLY SIRONA Inc. | 2.27B | - | 2,600,972 | 3.64B |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.27B | - | 162,268 | - |
| 252 | CLOV | Clover Health Investments, Corp. | 2.26B | - | 2,065,895 | 2.48B |
| 253 | UFPT | UFP Technologies, Inc. | 2.24B | - | 105,518 | 631.64M |
| 254 | NEO | NeoGenomics, Inc. | 2.23B | -0.46% | 997,013 | 766.30M |
| 255 | KOD | Kodiak Sciences Inc. | 2.22B | - | 675,921 | - |
| 256 | ESTA | Establishment Labs Holdings Inc. | 2.21B | - | 357,447 | 245.82M |
| 257 | RAPP | Rapport Therapeutics, Inc. | 2.20B | - | 279,885 | 20.00M |
| 258 | ADUS | Addus HomeCare Corporation | 2.17B | - | 177,121 | 1.48B |
| 259 | URGN | UroGen Pharma Ltd. | 2.16B | - | 779,043 | 188.73M |
| 260 | ADMA | ADMA Biologics, Inc. | 2.15B | - | 1,405,858 | 512.28M |
| 261 | MD | Pediatrix Medical Group, Inc. | 2.14B | - | 532,947 | 1.95B |
| 262 | ZBIO | Zenas BioPharma, Inc. | 2.14B | - | 452,691 | 1.00M |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | - | 526,595 | 311.51M |
| 264 | ALMR | Alamar Biosciences, Inc. | 2.14B | - | 142,950 | 100.42M |
| 265 | KLRA | Kailera Therapeutics, Inc. | 2.10B | - | 524,424 | - |
| 266 | GENB | Generate Biomedicines, Inc. | 2.10B | - | 725,333 | 26.48M |
| 267 | MESO | Mesoblast Limited | 2.09B | - | 93,499 | 120.25M |
| 268 | NVCR | NovoCure Limited | 2.09B | - | 732,170 | 699.19M |
| 269 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | - | 302,046 | - |
| 270 | ZYME | Zymeworks Inc. | 2.07B | - | 476,599 | 37.13M |
| 271 | PRGO | Perrigo Company plc | 2.07B | - | 2,197,095 | 4.14B |
| 272 | VCEL | Vericel Corporation | 2.06B | - | 312,915 | 306.30M |
| 273 | PGNY | Progyny, Inc. | 1.99B | - | 1,057,015 | 1.31B |
| 274 | XNCR | Xencor, Inc. | 1.98B | - | 919,792 | 104.97M |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | - | 480,161 | 98.34M |
| 276 | ASTH | Astrana Health, Inc. | 1.97B | - | 241,954 | 3.84B |
| 277 | BFLY | Butterfly Network, Inc. | 1.96B | - | 3,050,577 | 112.14M |
| 278 | NBTX | Nanobiotix S.A. | 1.96B | - | 119,298 | 38.27M |
| 279 | KARD | Kardigan, Inc. | 1.95B | - | 279,615 | - |
| 280 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | 5.52% | 29,039,059 | 54.86M |
| 281 | GHRS | GH Research PLC | 1.94B | - | 78,099 | - |
| 282 | VIR | Vir Biotechnology, Inc. | 1.93B | - | 1,152,061 | 303.23M |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.92B | -0.60% | 714,062 | 27.59M |
| 284 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | -0.68% | 1,552,057 | 208.78M |
| 285 | ALVO | Alvotech | 1.90B | - | 535,402 | 494.61M |
| 286 | IMCR | Immunocore Holdings plc | 1.86B | - | 231,712 | 430.78M |
| 287 | DMRA | Damora Therapeutics, Inc. | 1.86B | - | 295,833 | - |
| 288 | SGRY | Surgery Partners, Inc. | 1.85B | - | 1,106,623 | 3.37B |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.85B | - | 208,179 | 1.13B |
| 290 | LMAT | LeMaitre Vascular, Inc. | 1.84B | - | 167,362 | 262.43M |
| 291 | CMPS | COMPASS Pathways plc | 1.84B | - | 794,908 | - |
| 292 | PSNL | Personalis, Inc. | 1.84B | - | 2,522,867 | 69.67M |
| 293 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | - | 1,360,749 | 252.25M |
| 294 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | - | 2,111,279 | 5.49M |
| 295 | INSP | Inspire Medical Systems, Inc. | 1.82B | - | 425,724 | 898.74M |
| 296 | SNDA | Sonida Senior Living, Inc. | 1.79B | - | 755,451 | 481.07M |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.79B | - | 2,796,288 | 59.51M |
| 298 | INBX | Inhibrx Biosciences, Inc. | 1.78B | - | 196,513 | 1.30M |
| 299 | FRNM | Freenome, Inc. | 1.75B | - | 622,009 | 35.41M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.72B | - | 344,312 | 106.69M |
| 301 | BRVE | Braveheart Bio, Inc. | 1.72B | - | 272,081 | - |
| 302 | SEPN | Septerna, Inc. | 1.72B | - | 199,667 | 98.88M |
| 303 | TYRA | Tyra Biosciences, Inc. | 1.71B | - | 1,864,601 | - |
| 304 | NVAX | Novavax, Inc. | 1.69B | - | 5,125,027 | 413.80M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.68B | - | 762,080 | 2.68B |
| 306 | ANAB | AnaptysBio, Inc. | 1.68B | - | 1,061,883 | 232.39M |
| 307 | ETON | Eton Pharmaceuticals, Inc. | 1.67B | - | 521,604 | 105.60M |
| 308 | AVLN | Avalyn Pharma Inc. | 1.66B | - | 243,510 | - |
| 309 | SLBT | SL Science Holding Limited | 1.64B | - | 68,575 | 3.27M |
| 310 | LBRX | LB Pharmaceuticals Inc | 1.59B | - | 205,964 | - |
| 311 | AAPG | Ascentage Pharma Group International | 1.58B | - | 5,099 | 94.61M |
| 312 | OMCL | Omnicell, Inc. | 1.57B | - | 873,123 | 1.25B |
| 313 | XERS | Xeris Biopharma Holdings, Inc. | 1.56B | - | 1,030,533 | 335.41M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.55B | - | 176,419 | 1.52B |
| 315 | INVA | Innoviva, Inc. | 1.54B | - | 563,508 | 440.00M |
| 316 | ARDT | Ardent Health, Inc. | 1.54B | - | 449,033 | 6.41B |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.53B | - | 296,877 | - |
| 318 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | - | 219,218 | 978.38M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.53B | - | 182,982 | - |
| 320 | APMD | Apnimed, Inc. | 1.52B | - | 233,022 | 120.15M |
| 321 | ABSI | Absci Corporation | 1.51B | - | 2,150,231 | 1.56M |
| 322 | AKTS | Aktis Oncology, Inc. | 1.50B | - | 159,249 | 10.06M |
| 323 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | 3.03% | 11,494,472 | 717.00M |
| 324 | SDGR | Schrödinger, Inc. | 1.50B | - | 877,064 | 259.04M |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.50B | - | 593,954 | 1.86B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | - | 181,777 | 95.13M |
| 327 | AGL | agilon health, inc. | 1.49B | - | 125,900 | 5.92B |
| 328 | VOR | Vor Biopharma Inc. | 1.48B | - | 421,764 | - |
| 329 | CNMD | CONMED Corporation | 1.48B | - | 281,284 | 1.37B |
| 330 | ATEC | Alphatec Holdings, Inc. | 1.46B | - | 1,581,074 | 815.05M |
| 331 | INNV | InnovAge Holding Corp. | 1.46B | - | 161,443 | 949.17M |
| 332 | LTGO | Latigo Biotherapeutics, Inc. | 1.46B | - | 227,438 | - |
| 333 | MAZE | Maze Therapeutics, Inc. | 1.46B | - | 273,269 | 20.00M |
| 334 | TRAX | First Tracks Biotherapeutics, Inc. | 1.45B | - | 456,232 | - |
| 335 | HROW | Harrow, Inc. | 1.44B | - | 229,022 | 275.59M |
| 336 | ALMS | Alumis Inc. | 1.44B | - | 3,078,140 | 7.40M |
| 337 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | - | 562,486 | - |
| 338 | REPL | Replimune Group, Inc. | 1.42B | - | 910,230 | - |
| 339 | ANRO | Alto Neuroscience, Inc. | 1.40B | - | 269,947 | - |
| 340 | OMDA | Omada Health, Inc. | 1.39B | - | 877,387 | 309.76M |
| 341 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 2.80% | 752,110 | - |
| 342 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | - | 1,363,548 | 1.04B |
| 343 | ODTX | Odyssey Therapeutics, Inc. | 1.38B | - | 268,975 | 99.00K |
| 344 | AZTA | Azenta, Inc. | 1.37B | - | 751,929 | 613.81M |
| 345 | OMER | Omeros Corporation | 1.37B | - | 892,193 | 38.42M |
| 346 | SVRA | Savara Inc. | 1.36B | - | 625,457 | - |
| 347 | MGTX | MeiraGTx Holdings plc | 1.33B | - | 531,145 | 397.50M |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | - | 991,453 | - |
| 349 | SPTX | Seaport Therapeutics, Inc. | 1.33B | - | 104,338 | - |
| 350 | PNTG | The Pennant Group, Inc. | 1.33B | - | 174,310 | 1.10B |
| 351 | NUTX | Nutex Health Inc. | 1.32B | - | 142,280 | 846.72M |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.31B | - | 581,262 | 3.43B |
| 353 | IMTX | Immatics N.V. | 1.31B | 1.06% | 497,160 | 47.65M |
| 354 | MNKD | MannKind Corporation | 1.31B | - | 2,807,581 | 393.63M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.30B | - | 1,276,669 | 337.34M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.30B | - | 674,914 | 1.65B |
| 357 | MLTX | MoonLake Immunotherapeutics | 1.28B | - | 1,428,700 | - |
| 358 | JBIO | Jade Biosciences, Inc. | 1.27B | - | 605,018 | - |
| 359 | AORT | Artivion, Inc. | 1.25B | - | 418,343 | 471.47M |
| 360 | JANX | Janux Therapeutics, Inc. | 1.24B | - | 700,775 | 24.00M |
| 361 | OPK | OPKO Health, Inc. | 1.22B | 1.86% | 2,350,122 | 587.90M |
| 362 | CERT | Certara, Inc. | 1.21B | -2.34% | 1,272,274 | 421.75M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | - | 626,950 | - |
| 364 | CRON | Cronos Group Inc. | 1.20B | - | 493,811 | 179.09M |
| 365 | GDRX | GoodRx Holdings, Inc. | 1.19B | - | 854,870 | 785.23M |
| 366 | USPH | U.S. Physical Therapy, Inc. | 1.18B | - | 91,804 | 804.27M |
| 367 | BVS | Bioventus Inc. | 1.18B | - | 502,334 | 581.85M |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | - | 804,585 | 28.73M |
| 369 | KURA | Kura Oncology, Inc. | 1.18B | 0.76% | 1,313,519 | 77.23M |
| 370 | STAA | STAAR Surgical Company | 1.18B | - | 1,974,181 | 339.59M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | - | 250,656 | 1.04B |
| 372 | ATTO | Attovia Therapeutics, Inc. | 1.17B | - | 311,049 | 1.80M |
| 373 | SANA | Sana Biotechnology, Inc. | 1.15B | - | 1,239,920 | - |
| 374 | TDOC | Teladoc Health, Inc. | 1.14B | - | 2,957,364 | 2.49B |
| 375 | IVA | Inventiva S.A. | 1.10B | -1.24% | 1,350,616 | 7.94M |
| 376 | SLDB | Solid Biosciences Inc. | 1.10B | - | 495,328 | - |
| 377 | ENOV | Enovis Corporation | 1.07B | - | 1,886,852 | 2.30B |
| 378 | IRMD | IRADIMED CORPORATION | 1.07B | - | 233,294 | 86.34M |
| 379 | PCRX | Pacira BioSciences, Inc. | 1.05B | - | 481,690 | 746.16M |
| 380 | GMRS | GMR Solutions Inc. | 1.05B | - | 470,552 | 5.88B |
| 381 | OBX | Obsidian Therapeutics, Inc. | 1.04B | - | 140,120 | - |
| 382 | FTH | Faeth Therapeutics, Inc. | 1.03B | - | 275,249 | - |
| 383 | AVTX | Avalo Therapeutics, Inc. | 1.03B | - | 633,231 | 59.00K |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.02B | - | 5,198,304 | 181.72M |
| 385 | GERN | Geron Corporation | 1.01B | - | 11,478,946 | 204.56M |
| 386 | CSTL | Castle Biosciences, Inc. | 1.01B | - | 187,726 | 357.28M |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | - | 1,044,611 | 41.47M |
| 388 | IMMX | Immix Biopharma, Inc. | 995.11M | - | 1,050,694 | - |
| 389 | AMPH | Amphastar Pharmaceuticals, Inc. | 986.03M | - | 650,129 | 730.02M |
| 390 | CADL | Candel Therapeutics, Inc. | 977.91M | - | 535,822 | - |
| 391 | SGP | SpyGlass Pharma, Inc. | 967.98M | - | 75,093 | - |
| 392 | ANL | Adlai Nortye Group Ltd. | 966.61M | - | 308,575 | 18.06M |
| 393 | QDEL | QuidelOrtho Corporation | 958.00M | - | 890,257 | 2.67B |
| 394 | WVE | Wave Life Sciences, Inc. | 957.65M | - | 3,030,267 | 65.37M |
| 395 | CBLL | CeriBell, Inc. | 948.71M | - | 223,608 | 101.96M |
| 396 | DSGN | Design Therapeutics, Inc. | 947.49M | - | 256,618 | - |
| 397 | ARDX | Ardelyx, Inc. | 941.93M | - | 2,982,312 | 450.89M |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 940.60M | - | 505,266 | - |
| 399 | ANNX | Annexon, Inc. | 923.25M | - | 1,227,543 | - |
| 400 | RIGL | Rigel Pharmaceuticals, Inc. | 909.15M | - | 104,968 | 276.79M |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 908.22M | - | 1,746,646 | 8.22M |
| 402 | CBIO | Crescent Biopharma, Inc. | 893.69M | - | 239,696 | 11.88M |
| 403 | HELP | Cybin Inc. | 892.80M | - | 1,026,782 | - |
| 404 | CLYM | Climb Bio, Inc. | 891.41M | - | 1,495,361 | - |
| 405 | TBPH | Theravance Biopharma, Inc. | 886.77M | - | 160,550 | 104.31M |
| 406 | AVR | Anteris Technologies Global Corp. | 881.02M | - | 362,901 | 2.24M |
| 407 | SLN | Silence Therapeutics plc | 878.45M | - | 611,151 | 615.00K |
| 408 | BBNX | Beta Bionics, Inc. | 873.70M | - | 1,407,468 | 119.01M |
| 409 | ACHV | Achieve Life Sciences, Inc. | 873.64M | - | 886,366 | - |
| 410 | AHCO | AdaptHealth Corp. | 865.83M | - | 2,614,814 | 3.36B |
| 411 | INMD | InMode Ltd. | 857.04M | - | 449,386 | 374.63M |
| 412 | HSTM | HealthStream, Inc. | 853.81M | - | 203,456 | 321.12M |
| 413 | GLAS | Glass House Brands Inc. | 836.87M | - | 482,893 | 176.98M |
| 414 | SIBN | SI-BONE, Inc. | 829.14M | - | 389,532 | 213.60M |
| 415 | FDMT | 4D Molecular Therapeutics, Inc. | 827.01M | - | 420,636 | 92.01M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 808.41M | - | 2,297,761 | 18.30M |
| 417 | PHAR | Pharming Group N.V. | 808.19M | - | 5,544 | 366.48M |
| 418 | DBVT | DBV Technologies S.A. | 800.35M | - | 43,079 | 5.04M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 797.92M | - | 117,165 | - |
| 420 | MNPR | Monopar Therapeutics Inc. | 789.08M | - | 82,246 | - |
| 421 | AURA | Aura Biosciences, Inc. | 784.01M | - | 456,396 | - |
| 422 | VREX | Varex Imaging Corporation | 780.16M | - | 253,647 | 865.00M |
| 423 | AGMB | AgomAb Therapeutics NV | 777.13M | - | 245,268 | - |
| 424 | NGNE | Neurogene Inc. | 772.44M | - | 205,634 | 925.00K |
| 425 | COLL | Collegium Pharmaceutical, Inc. | 766.03M | - | 901,142 | 808.21M |
| 426 | MPLT | MapLight Therapeutics, Inc. | 765.28M | - | 550,857 | - |
| 427 | PHAT | Phathom Pharmaceuticals, Inc. | 754.59M | - | 1,236,691 | 239.66M |
| 428 | OCS | Oculis Holding AG | 751.28M | - | 124,347 | 1.45M |
| 429 | ASMB | Assembly Biosciences, Inc. | 745.20M | - | 156,452 | 74.85M |
| 430 | VSTM | Verastem, Inc. | 742.62M | 2.76% | 2,301,509 | 87.53M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 736.36M | - | 1,030,005 | 136.07M |
| 432 | GYRE | Gyre Therapeutics, Inc. | 727.39M | - | 56,023 | 109.82M |
| 433 | AHG | Akso Health Group | 726.49M | - | 2,649 | 13.83M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 719.96M | - | 117,621 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 703.92M | - | 829,291 | 389.32M |
| 436 | SOPH | SOPHiA GENETICS SA | 688.68M | - | 147,033 | 86.17M |
| 437 | SSII | SS Innovations International, Inc. | 683.31M | - | 21,845 | 52.40M |
| 438 | STTK | Shattuck Labs, Inc. | 681.47M | - | 677,764 | 1.00M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 680.62M | - | 4,428,568 | 4.64M |
| 440 | SGMT | Sagimet Biosciences Inc. | 680.02M | - | 1,250,060 | - |
| 441 | PHR | Phreesia, Inc. | 679.06M | - | 807,904 | 507.79M |
| 442 | BLSM | BlossomHill Therapeutics, Inc. | 674.47M | - | 168,707 | - |
| 443 | AQST | Aquestive Therapeutics, Inc. | 670.23M | - | 2,117,771 | 54.09M |
| 444 | MDXG | MiMedx Group, Inc. | 666.13M | - | 624,972 | 355.17M |
| 445 | ALT | Altimmune, Inc. | 665.25M | 5.88% | 4,871,948 | 31.00K |
| 446 | EVO | Evotec SE | 664.29M | - | 121,908 | 819.47M |
| 447 | PRME | Prime Medicine, Inc. | 658.25M | - | 1,619,295 | 4.07M |
| 448 | CRMD | CorMedix Inc. | 657.07M | - | 792,913 | 462.25M |
| 449 | DRUG | Bright Minds Biosciences Inc. | 656.57M | - | 93,013 | - |
| 450 | CTEV | Claritev Corporation | 651.29M | - | 70,574 | 994.67M |
| 451 | VALN | Valneva SE | 637.30M | - | 22,866 | 163.30M |
| 452 | OABI | OmniAb, Inc. | 629.54M | - | 1,703,973 | 38.46M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 628.27M | - | 346,230 | - |
| 454 | ANGO | AngioDynamics, Inc. | 628.25M | - | 527,438 | 320.17M |
| 455 | TLRY | Tilray Brands, Inc. | 616.46M | - | 2,763,965 | 915.45M |
| 456 | EOLS | Evolus, Inc. | 614.27M | - | 696,365 | 316.49M |
| 457 | ARVN | Arvinas, Inc. | 613.98M | - | 449,299 | 316.70M |
| 458 | CTKB | Cytek Biosciences, Inc. | 610.92M | - | 478,226 | 206.71M |
| 459 | PROK | ProKidney Corp. | 607.67M | - | 1,225,328 | 818.00K |
| 460 | STLN | Starling Oncology, Inc. | 604.36M | - | 466,625 | 587.24M |
| 461 | TECX | Tectonic Therapeutic, Inc. | 601.14M | - | 159,290 | - |
| 462 | ZURA | Zura Bio Limited | 597.02M | - | 1,389,478 | - |
| 463 | AUTL | Autolus Therapeutics plc | 596.20M | - | 1,836,157 | 117.39M |
| 464 | RGNX | REGENXBIO Inc. | 590.16M | - | 1,070,570 | 174.48M |
| 465 | CABA | Cabaletta Bio, Inc. | 588.32M | - | 4,893,142 | - |
| 466 | EIKN | Eikon Therapeutics, Inc. | 588.23M | - | 238,698 | - |
| 467 | WEAV | Weave Communications, Inc. | 586.39M | - | 2,193,936 | 257.79M |
| 468 | KIDS | OrthoPediatrics Corp. | 585.12M | - | 129,507 | 252.72M |
| 469 | DCTH | Delcath Systems, Inc. | 571.84M | - | 180,916 | 95.42M |
| 470 | PRLD | Prelude Therapeutics Incorporated | 562.35M | - | 400,285 | 22.42M |
| 471 | SPRY | ARS Pharmaceuticals, Inc. | 558.89M | - | 852,848 | 116.93M |
| 472 | BWAY | BrainsWay Ltd. | 557.83M | -2.48% | 49,630 | 60.70M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 554.49M | - | 3,520,932 | - |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 547.08M | - | 168,592 | 251.00K |
| 475 | OVID | Ovid Therapeutics Inc. | 546.83M | - | 1,066,038 | 1.58M |
| 476 | CAPR | Capricor Therapeutics, Inc. | 546.51M | - | 2,555,652 | 11.13M |
| 477 | FLGT | Fulgent Genetics, Inc. | 542.88M | - | 224,999 | 323.93M |
| 478 | SCTX | Scribe Therapeutics Inc. | 542.77M | - | 148,197 | 33.30M |
| 479 | CERS | Cerus Corporation | 521.95M | - | 1,102,631 | 221.55M |
| 480 | ENTX | Entera Bio Ltd. | 519.43M | - | 606,922 | 42.00K |
| 481 | NPCE | NeuroPace, Inc. | 511.43M | - | 92,321 | 106.99M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 510.21M | - | 500,823 | - |
| 483 | SENS | Senseonics Holdings, Inc. | 509.18M | - | 425,575 | 48.55M |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 485 | PRTA | Prothena Corporation plc | 504.13M | - | 383,928 | 54.53M |
| 486 | EDIT | Editas Medicine, Inc. | 496.06M | - | 1,390,714 | 47.01M |
| 487 | TCMD | Tactile Systems Technology, Inc. | 495.41M | - | 197,932 | 350.31M |
| 488 | PBYI | Puma Biotechnology, Inc. | 492.97M | - | 185,911 | 231.24M |
| 489 | EVH | Evolent Health, Inc. | 488.42M | - | 1,728,600 | 2.10B |
| 490 | RZLT | Rezolute, Inc. | 478.46M | - | 716,948 | - |
| 491 | KMDA | Kamada Ltd. | 477.05M | - | 160,809 | 191.85M |
| 492 | NRC | NRC Health | 476.23M | - | 141,621 | 140.00M |
| 493 | RLMD | Relmada Therapeutics, Inc. | 472.55M | - | 675,556 | - |
| 494 | SRTA | Strata Critical Medical, Inc. | 470.64M | - | 650,326 | 255.98M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.01M | - | 656,659 | 132.42M |
| 496 | AVIR | Atea Pharmaceuticals, Inc. | 467.59M | - | 204,140 | - |
| 497 | GALT | Galectin Therapeutics Inc. | 464.92M | - | 473,554 | - |
| 498 | CCCC | C4 Therapeutics, Inc. | 462.57M | 0.53% | 2,363,367 | 35.04M |
| 499 | OCGN | Ocugen, Inc. | 461.19M | - | 3,567,526 | 4.58M |
| 500 | SGHT | Sight Sciences, Inc. | 459.98M | - | 102,466 | 83.38M |